Public Health

How Do Household Chemicals Affect Breast Cancer Risk?
Clinical & Pharma How Do Household Chemicals Affect Breast Cancer Risk?

In the quiet corners of homes, where daily life unfolds amidst familiar surroundings, an invisible threat may be lurking in the form of household chemicals that could influence serious health outcomes like breast cancer. Many individuals spend the majority of their time indoors, surrounded by

Poor Oral Health May Impact Cognitive Function and Brain Health
Clinical & Pharma Poor Oral Health May Impact Cognitive Function and Brain Health

Emerging research is uncovering a startling connection between the state of one's mouth and the health of the brain, suggesting that neglecting dental care could have far-reaching consequences beyond just cavities or gum issues. For years, oral health was often considered a standalone concern,

Barcode Errors Pose Fatal Risks, Warns Safety Commissioner
Clinical & Pharma Barcode Errors Pose Fatal Risks, Warns Safety Commissioner

In the United Kingdom, a seemingly minor issue with medicine packaging is spiraling into a major threat to public health, as barcode errors on drug packs put countless lives at risk, leading to potential catastrophic mistakes. These errors, whether due to missing information or incorrect labeling,

Cuban Regime Blames Citizens for Health Crisis Woes
Clinical & Pharma Cuban Regime Blames Citizens for Health Crisis Woes

In the heart of Cuba, a severe epidemiological crisis is unfolding, driven by the relentless spread of the Aedes aegypti mosquito and the alarming rise of arboviral diseases that threaten public health across the nation, setting the stage for a deeper exploration of the tactics and implications

How Will HSRI and AstraZeneca Transform Thai Healthcare?
Clinical & Pharma How Will HSRI and AstraZeneca Transform Thai Healthcare?

In a landmark move for Thailand’s medical landscape, the Health Systems Research Institute (HSRI) and AstraZeneca (Thailand) Co., Ltd. have forged a powerful partnership through a recently signed Memorandum of Understanding (MOU). This collaboration, centered on advancing clinical research within

Endometrial Cancer Risk Models: Insights and Clinical Limits
Clinical & Pharma Endometrial Cancer Risk Models: Insights and Clinical Limits

Endometrial cancer (EC), recognized as the most prevalent gynecologic malignancy in high-income nations, continues to pose a significant public health challenge with its incidence on a steady rise, largely fueled by escalating obesity rates and other modifiable lifestyle factors. The stakes for

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later